1. Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring. Issue 12 (14th July 2013) Authors: He, Y. L.; Foteinos, G.; Neelakantham, S.; Mattapalli, D.; Kulmatycki, K.; Forst, T.; Taylor, A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 12(2013:Dec.) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD‐5). Issue 8 (22nd May 2014) Authors: Skrivanek, Z.; Gaydos, B. L.; Chien, J. Y.; Geiger, M. J.; Heathman, M. A.; Berry, S.; Anderson, J. H.; Forst, T.; Milicevic, Z.; Berry, D. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 8(2014:Aug.) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early fasting glucose measurements can predict later glycaemic response to once weekly dulaglutide. Issue 3 (21st July 2015) Authors: Grunberger, G.; Forst, T.; Fernández Landó, L.; Pechtner, V.; Shaginian, R.; Jia, N.; Gough, S. Journal: Diabetic medicine Issue: Volume 33:Issue 3(2016:Mar.) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus. Issue 6 (6th February 2013) Authors: Forst, T.; Dworak, M.; Berndt‐Zipfel, C.; Löffler, A.; Klamp, I.; Mitry, M.; Pfützner, A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 6(2013:Jun.) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Issue 5 (12th March 2014) Authors: Forst, T.; Guthrie, R.; Goldenberg, R.; Yee, J.; Vijapurkar, U.; Meininger, G.; Stein, P. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 5(2014:May) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Performance of blood glucose meters in compliance with current and future clinical ISO15197 accuracy criteria. (February 2014) Authors: Pfützner, A.; Hengesbach, C.; Demircik, F.; Schipper, C.; Forst, T.; Musholt, P.B. Journal: Current medical research and opinion Issue: Volume 30:Number 2(2014:Feb.) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin. Issue 7 (25th February 2013) Authors: Kapitza, C.; Forst, T.; Coester, H.‐V.; Poitiers, F.; Ruus, P.; Hincelin‐Méry, A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 7(2013:Jul.) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Role of C-Peptide in the Regulation of Microvascular Blood Flow. (28th July 2008) Authors: Forst, T.; Kunt, T.; Wilhelm, B.; Weber, M. M.; Pfützner, A. Other Names: King George Academic Editor. Journal: Experimental diabetes research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control. (October 2014) Authors: Pfützner, A.; Dissel, S.; Forkel, C.; Grenningloh, M.; Bitton, G.; Nagar, R.; Forst, T. Journal: Current medical research and opinion Issue: Volume 30:Number 10(2014:Oct.) Page Start: 2001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus. (May 2014) Authors: Pfützner, A.; Hermanns, N.; Funke, K.; Forst, T.; Behnke, T.; Bitton, G.; Nagar, R.; Raz, I.; Haak, T. Journal: Current medical research and opinion Issue: Volume 30:Number 5(2014:May) Page Start: 753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗